Annual Accounts Payable
$38.57 M
+$1.06 M+2.81%
December 31, 2024
Summary
- As of March 10, 2025, APLS annual accounts payable is $38.57 million, with the most recent change of +$1.06 million (+2.81%) on December 31, 2024.
- During the last 3 years, APLS annual accounts payable has risen by +$21.66 million (+128.12%).
- APLS annual accounts payable is now at all-time high.
Performance
APLS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$38.57 M
-$4.16 M-9.73%
December 31, 2024
Summary
- As of March 10, 2025, APLS quarterly accounts payable is $38.57 million, with the most recent change of -$4.16 million (-9.73%) on December 31, 2024.
- Over the past year, APLS quarterly accounts payable has stayed the same.
- APLS quarterly accounts payable is now -9.73% below its all-time high of $42.73 million, reached on September 30, 2024.
Performance
APLS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
APLS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.8% | 0.0% |
| 3 y3 years | +128.1% | +128.1% |
| 5 y5 years | +361.3% | +128.1% |
APLS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +128.1% | -9.7% | +214.3% |
| 5 y | 5-year | at high | +361.3% | -9.7% | +1153.2% |
| alltime | all time | at high | >+9999.0% | -9.7% | +5032.7% |
Apellis Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $38.57 M(+2.8%) | $38.57 M(-9.7%) |
| Sep 2024 | - | $42.73 M(+11.7%) |
| Jun 2024 | - | $38.27 M(+42.9%) |
| Mar 2024 | - | $26.79 M(-28.6%) |
| Dec 2023 | $37.52 M(+0.5%) | $37.52 M(+106.2%) |
| Sep 2023 | - | $18.19 M(-33.8%) |
| Jun 2023 | - | $27.50 M(-12.7%) |
| Mar 2023 | - | $31.49 M(-15.7%) |
| Dec 2022 | $37.34 M(+120.8%) | $37.34 M(+164.9%) |
| Sep 2022 | - | $14.10 M(-13.1%) |
| Jun 2022 | - | $16.22 M(+32.2%) |
| Mar 2022 | - | $12.27 M(-27.4%) |
| Dec 2021 | $16.91 M(+99.5%) | $16.91 M(+239.3%) |
| Sep 2021 | - | $4.98 M(-6.6%) |
| Jun 2021 | - | $5.34 M(+28.4%) |
| Mar 2021 | - | $4.16 M(-50.9%) |
| Dec 2020 | $8.48 M | $8.48 M(-23.4%) |
| Sep 2020 | - | $11.07 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $9.93 M(+222.5%) |
| Mar 2020 | - | $3.08 M(-63.2%) |
| Dec 2019 | $8.36 M(-18.5%) | $8.36 M(-29.4%) |
| Sep 2019 | - | $11.84 M(-14.3%) |
| Jun 2019 | - | $13.81 M(+15.9%) |
| Mar 2019 | - | $11.92 M(+16.2%) |
| Dec 2018 | $10.25 M(+179.9%) | $10.25 M(+87.5%) |
| Sep 2018 | - | $5.47 M(+6.5%) |
| Jun 2018 | - | $5.13 M(+11.9%) |
| Mar 2018 | - | $4.59 M(+25.2%) |
| Dec 2017 | $3.66 M(+43.8%) | $3.66 M(-8.4%) |
| Sep 2017 | - | $4.00 M(+53.6%) |
| Jun 2017 | - | $2.60 M(+2.2%) |
| Dec 2016 | $2.55 M(+2.8%) | $2.55 M(+2.8%) |
| Dec 2015 | $2.48 M(+229.7%) | $2.48 M(+95.4%) |
| Sep 2015 | - | $1.27 M(+52.7%) |
| Jun 2015 | - | $830.20 K(+10.5%) |
| Dec 2014 | $751.50 K(+112.3%) | $751.50 K |
| Dec 2013 | $353.90 K | - |
FAQ
- What is Apellis Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual accounts payable year-on-year change?
- What is Apellis Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly accounts payable year-on-year change?
What is Apellis Pharmaceuticals annual accounts payable?
The current annual accounts payable of APLS is $38.57 M
What is the all time high annual accounts payable for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual accounts payable is $38.57 M
What is Apellis Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, APLS annual accounts payable has changed by +$1.06 M (+2.81%)
What is Apellis Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of APLS is $38.57 M
What is the all time high quarterly accounts payable for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly accounts payable is $42.73 M
What is Apellis Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, APLS quarterly accounts payable has changed by $0.00 (0.00%)